Keyphrases
Adenocarcinoma
25%
Carcinoma in Situ
45%
Cervical Cancer
82%
Cervical Cancer Screening
40%
Cervical Intraepithelial Neoplasia
34%
Cervical Intraepithelial Neoplasia Grade 3
20%
Cervical Lesions
23%
Cervical Samples
39%
Clostridium Perfringens
20%
Computed Tomography
20%
Copenhagen
20%
Danish Population
25%
Denmark
67%
Epidemiological Study
20%
Estimated Annual Percentage Change
20%
Europe
20%
Genital
20%
High-grade Cervical Intraepithelial Neoplasia
20%
High-risk Human Papillomavirus (HR-HPV)
43%
Histology
23%
HPV Types
20%
HPV16
50%
HPV18
20%
Human Papillomavirus Genotypes
20%
Human Papillomavirus Prevalence
20%
Human Papillomavirus Testing
17%
Human Papillomavirus Types
54%
Human Papillomavirus Vaccine
15%
Intrauterine Infection
20%
Invasive Cervical Cancer
40%
Life-threatening
20%
Liquid-based Cytology
60%
Older Women
16%
Organized Screening Program
26%
Papanicolaou Smear
40%
Population Screening
40%
Precancerous Lesions
20%
Prevalence Distribution
20%
Screening History
20%
Screening Program
17%
Squamous Cell Carcinoma (SqCC)
28%
SurePath
40%
ThinPrep
20%
Type Distribution
45%
Young Women
18%
Medicine and Dentistry
Adenocarcinoma in Situ
21%
Cervical Cancer
100%
Cervical Intraepithelial Neoplasia
30%
Clostridium perfringens
20%
Cytotechnology
23%
Human Papillomavirus Type 16
36%
Human Papillomavirus Type 18
21%
Liquid-Based Cytology
50%
Mass Screening
23%
Neoplasm
20%
Papanicolaou Stain
30%
Prevalence
25%
Screening
50%
Wart Virus
60%
